714 related articles for article (PubMed ID: 28237749)
21. Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy.
Emami J; Rezazadeh M; Rostami M; Hassanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Lavasanifar A
Drug Dev Ind Pharm; 2015; 41(7):1137-47. PubMed ID: 25019502
[TBL] [Abstract][Full Text] [Related]
22. Redox-Sensitive Micelles Based on O,N-Hydroxyethyl Chitosan-Octylamine Conjugates for Triggered Intracellular Delivery of Paclitaxel.
Huo M; Liu Y; Wang L; Yin T; Qin C; Xiao Y; Yin L; Liu J; Zhou J
Mol Pharm; 2016 Jun; 13(6):1750-62. PubMed ID: 27100204
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
[TBL] [Abstract][Full Text] [Related]
24. Poly(cystine-PCL) based pH/redox dual-responsive nanocarriers for enhanced tumor therapy.
Zhang X; Kang Y; Liu GT; Li DD; Zhang JY; Gu ZP; Wu J
Biomater Sci; 2019 Apr; 7(5):1962-1972. PubMed ID: 30810135
[TBL] [Abstract][Full Text] [Related]
25. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
[TBL] [Abstract][Full Text] [Related]
26. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
27. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
[TBL] [Abstract][Full Text] [Related]
28. Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer.
Emami J; Kazemi M; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A
Pharm Dev Technol; 2020 Apr; 25(4):492-509. PubMed ID: 31903817
[TBL] [Abstract][Full Text] [Related]
29. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
[TBL] [Abstract][Full Text] [Related]
30. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
[TBL] [Abstract][Full Text] [Related]
31. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
32. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
Chu XY; Huang W; Wang YL; Meng LW; Chen LQ; Jin MJ; Chen L; Gao CH; Ge C; Gao ZG; Gao CS
Int J Nanomedicine; 2019; 14():689-705. PubMed ID: 30774330
[TBL] [Abstract][Full Text] [Related]
33. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
[TBL] [Abstract][Full Text] [Related]
34. Nanoemulsion enhances α-tocopherol succinate bioavailability in rats.
Gao Y; Qi X; Zheng Y; Ji H; Wu L; Zheng N; Tang J
Int J Pharm; 2016 Dec; 515(1-2):506-514. PubMed ID: 27746330
[TBL] [Abstract][Full Text] [Related]
35. Reduction-Triggered Paclitaxel Release Nano-Hybrid System Based on Core-Crosslinked Polymer Dots with a pH-Responsive Shell-Cleavable Colorimetric Biosensor.
Kim SG; Ryplida B; Phuong PTM; Won HJ; Lee G; Bhang SH; Park SY
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661903
[TBL] [Abstract][Full Text] [Related]
36. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
38. Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Torchilin V; Biswas S
Nanomedicine (Lond); 2019 Dec; 14(24):3159-3176. PubMed ID: 31855118
[No Abstract] [Full Text] [Related]
39. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
Yu B; Tang C; Yin C
Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
